Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RTW Investments, LP | 5,640,593 9.990% | 2,285,768 (+68.13%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | BlackRock Inc. BLK | 4,050,686 7.600% | 4,050,686 (New Position) | Filing History |
| 2024-10-29 4:30 pm Purchase | 2024-09-30 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 2,778,525 5.200% | 1,047,636 (+60.53%) | Filing History |
| 2024-07-16 6:06 pm Purchase | 2024-07-14 | 13D | Milestone Pharmaceuticals Inc. MIST | Alta Fundamental Advisers LLC | 2,658,589 4.990% | 987,300 (+59.07%) | Filing History |
| 2024-02-14 8:56 pm Sale | 2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Venrock Healthcare Capital Partners III, L.P. | 925,048 2.800% | -1,283,764 (-58.12%) | Filing History |
| 2024-02-14 07:10 am Sale | 2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RTW Investments, LP | 3,354,825 9.990% | -960,277 (-22.25%) | Filing History |
| 2024-02-09 7:41 pm Sale | 2023-12-29 | 13G | Milestone Pharmaceuticals Inc. MIST | GOLDMAN SACHS GROUP INC GS | 1,359,540 4.100% | -1,390,845 (-50.57%) | Filing History |
| 2024-01-29 4:42 pm Sale | 2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 1,730,889 5.200% | -464,140 (-21.15%) | Filing History |
| 2024-01-24 2:27 pm Purchase | 2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | BlackRock Inc. BLK | 3,270,749 9.800% | 1,542,920 (+89.30%) | Filing |
| 2023-11-09 4:43 pm Purchase | 2023-11-06 | 13D | Milestone Pharmaceuticals Inc. MIST | Alta Fundamental Advisers LLC | 1,671,289 5.000% | 1,671,289 (New Position) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | ORBIMED CAPITAL LLC | 0 0.000% | -2,583,821 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RA Capital Management, L.P. | 0 0.000% | -2,246,503 (Position Closed) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Venrock Healthcare Capital Partners III, L.P. | 2,208,812 6.400% | 136,803 (+6.60%) | Filing History |
| 2023-02-14 1:13 pm Sale | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 698,861 2.000% | -1,540,000 (-68.78%) | Filing History |
| 2023-02-14 11:03 am Sale | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital LLC | 460,416 1.300% | -1,289,627 (-73.69%) | Filing History |
| 2023-02-13 09:06 am Purchase | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | BlackRock Inc. BLK | 1,727,829 5.000% | 1,727,829 (New Position) | Filing |
| 2023-01-19 09:19 am Purchase | 2022-12-30 | 13G | Milestone Pharmaceuticals Inc. MIST | GOLDMAN SACHS GROUP INC GS | 2,750,385 8.000% | 2,750,385 (New Position) | Filing History |
| 2023-01-18 4:40 pm Purchase | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 2,195,029 6.400% | 290,732 (+15.27%) | Filing History |
| 2022-10-31 4:40 pm Purchase | 2022-10-25 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 1,904,297 6.300% | 1,904,297 (New Position) | Filing History |
| 2022-10-24 12:46 pm Sale | 2022-10-20 | 13D | Milestone Pharmaceuticals Inc. MIST | Novo Holdings A/S | 1,378,538 4.600% | -719,175 (-34.28%) | Filing History |